Dow 10 Portfolio Series 39

The Trust consists of an equally dollar weighted portfolio of stocks of companies in the Dow Jones Industrial Average (“DJIA”) that have the highest dividend yields on September 25, 2019 (the “Security Selection Date”) and hold them for approximately 15 months.

The Sponsor believes that dividends play an important part in total return and that stocks that have higher dividend yields may also be undervalued. The Sponsor also believes that blue chip stocks that are undervalued have the potential for higher total returns over time. As a result of this strategy, the Trust invests significantly in the consumer staples and health care sectors.

The securities included in the Trust’s portfolio are the common stocks of companies listed on the DJIA with the highest dividend yields as of the Security Selection Date. The dividend yields were calculated by annualizing the last quarterly or semi-annual ordinary dividend declared and dividing the result by the market value of the security as of the close on the Security Selection Date.

As with all investments, you may lose some or all of your investment in the Trust. No assurance can be given that the Trust’s investment objective will be achieved. The Trust also might not perform as well as you expect. This can happen for reasons such as these:

• The Trust invests significantly in the consumer staples sector. As a result, the factors that impact the consumer staples sector will likely have a greater effect on this Trust than on a more broadly diversified Trust. General risks of companies in the consumer staples sector include cyclicality of revenues and earnings, economic recession, currency fluctuations, changing consumer tastes, extensive competition, product liability litigation and increased government regulation. A weak economy and its effect on consumer spending would adversely affect companies in the consumer staples sector.

• The Trust invests significantly in the health care sector. As a result, the factors that impact the health care sector will likely have a greater effect on this Trust than on a more broadly diversified Trust. General risks of companies in the health care sector include extensive competition, generic drug sales, the loss of patent protection, product liability litigation and increased government regulation.

• Share prices or dividend rates on the securities in the Trust may decline during the life of the Trust. There is no guarantee that share prices of the securities in the Trust will not decline and that the issuers of the securities will declare dividends in the future and, if declared, whether they will remain at current levels or increase over time.

• Inflation may lead to a decrease in the value of assets or income from investments.

• The Sponsor does not actively manage the portfolio. The Trust will generally hold, and may, when creating additional units, continue to buy, the same securities even though a security’s outlook, market value or yield may have changed.

See “Investment Risks” in Part A of the prospectus and “Risk Factors” in Part B of the prospectus for additional information.